Impact Factor
3.25
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.01
518 total citations
h5-index
29
h5 depth signal
Cited share
52.6%
92 of 175
Total citations
518
Citation footprint
Metric signal
2.84
External metric anchor
Self-citation
0.8%
4 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
233
China
81
India
22
Italy
13
United Kingdom
13
Citing Fields of Research
Oncology
194
Breast Cancer
127
Liver & Colon Cancer
101
Brain Imaging
91
Prostate Cancer
76
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
711
Articles tracked across the journal lifetime
Indexed publication set
175
92 cited publications
Last 12 months
166
27.7 publications/month
Open access share
4.2%
7 OA publications in the last year
Leading citing country
United States
233 citing publications
Leading citing field
Oncology
194 citing publications
Latest tracked publication
1 November 2026
10 recent records available
Coverage & Indexing History
v1n1, Sept. 2019-
v1n1, Sept. 2019-
Active Coverage
Research Focus & Classification
Indexed Subjects
Liver & Colon Cancer
Prostate Cancer
Breast Cancer
Brain Imaging
Oncology
Issuing & Sponsoring Bodies
issuing body
Radiological Society of North America
Broad Categories
Neoplasms
Radiology
Breast Cancer
Prostate Cancer
Liver & Colon Cancer
Brain Imaging
Lung Cancer
MeSH Descriptors
Diagnostic Imaging
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1148/rycan.260124
Open DOI
Risk-adapted MRI Protocols for the Detection of Clinically Significant Prostate Cancer
Diagnostic performance and clinical utility of prostate MRI protocols differed by prebiopsy risk category, with multiparametric MRI showing higher sensitivity in intermediate-risk patients and similar performance across protocols in low-...
02
DOI 10.1148/rycan.250617
Open DOI
Multimodal Transformer Integrating CT and Pathology for Postoperative Risk Stratification in Stage I Non–Small Cell Lung Cancer
A biologically interpretable multimodal artificial intelligence framework outperformed guideline-based postoperative risk stratification for stage I non–small cell lung cancer and identified patients who would benefit from adjuvant therapy.
03
04
05
DOI 10.1148/rycan.260468
Open DOI
Beyond Lesion Detection: MR Virtual Cytometry and the Next Generation of Prostate MRI
06
DOI 10.1148/rycan.260010
Open DOI
Management, Upgrade Rates, and Radiologic Surveillance of Screen-Detected High-Risk Breast Lesions
Screen-detected high-risk breast lesions showed clinically relevant rates of upgrade to (pre)malignancy after surgical excision and during radiologic surveillance, while completion of recommended radiologic surveillance remained suboptimal.
07
DOI 10.1148/rycan.269022
Open DOI
Open Benchmark AI Outperforms Radiologists in CT Detection of Pancreatic Ductal Adenocarcinoma
08
DOI 10.1148/rycan.260551
Open DOI
The Mammographic Audit and False-Negative Rates in the Era of Tomosynthesis Screening
09
DOI 10.1148/rycan.260212
Open DOI
Causes of False-Negative Screening Digital Breast Tomosynthesis Examinations: A Multireader Study
In a contemporary breast cancer screening setting with digital breast tomosynthesis and multimodal supplemental screening, approximately half of false-negative cancers were missed, one-quarter were true interval, and one-quarter were mam...
10
Bibliographical & Catalog Notes
Complemented by (work): Radiology 0033-8419 (DLC) 24011915 (OCoLC)1763380 (DNLM)0401260.
Complemented by (work): Radiology. Artificial intelligence 2638-6100 (OCoLC)1084294291 (DNLM)101746556.